An executive search professional with more than 20 years’ experience, Kerstin Roubin is a trusted and highly knowledgeable resource. Her extensive expertise in many different aspects of international industries makes her indispensable as a core member of some of our major global practices. Kerstin also contributes her expertise to Boyden’s Interim Management and Leadership Consulting Practices.
The impact of ESG investing is too significant to ignore and with the battle for funds at its peak, the biotech industry needs to be at the forefront of the agenda. With impending mandates, the pressure is firmly on businesses to start thinking about their ESG proposition and how it may positively influence and affect the wider industry.